Cargando…

Optimal treatment of early-stage ovarian cancer

BACKGROUND: There is no clear consensus regarding systemic treatment of early-stage ovarian cancer (OC). Clinical trials are challenging because of the relatively low incidence and good prognosis. Initial results of the International Collaborative Ovarian Neoplasm (ICON)1 trial demonstrated benefit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Collinson, F., Qian, W., Fossati, R., Lissoni, A., Williams, C., Parmar, M., Ledermann, J., Colombo, N., Swart, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037858/ https://www.ncbi.nlm.nih.gov/pubmed/24631948 http://dx.doi.org/10.1093/annonc/mdu116

Ejemplares similares

Initial toxicity assessment of ICON6: a randomised trial of cediranib plus chemotherapy in platinum-sensitive relapsed ovarian cancer
por: Raja, F A, et al.
Publicado: (2011)

A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis
por: Fruscio, R, et al.
Publicado: (2008)

First-line treatment of ovarian cancer: questions and controversies to address
por: Ledermann, Jonathan A.
Publicado: (2018)

Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial
por: Maggi, R, et al.
Publicado: (2006)

Frontline Maintenance Treatment for Ovarian Cancer
por: Elyashiv, Osnat, et al.
Publicado: (2021)

Medical treatment of early stage and rare histological variants of epithelial ovarian cancer
por: Cont, Nicoletta Tomasi, et al.
Publicado: (2015)

PARP inhibitors in ovarian cancer: Clinical evidence for informed treatment decisions
por: Ledermann, Jonathan A, et al.
Publicado: (2015)

Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer
por: Ledermann, Jonathan A., et al.
Publicado: (2019)

Ovarian cancer recurrence: is the definition of platinum resistance modified by PARPi and other intervening treatments? The evolving landscape in the management of platinum-resistant ovarian cancer
por: Flynn, Michael J., et al.
Publicado: (2022)

Olaparib treatment for BRCA-mutant ovarian cancer with leptomeningeal disease
por: Bangham, Madeleine, et al.
Publicado: (2016)

Ovarian cancer – American cancer society atlas of clinical oncology
por: Ledermann, J A
Publicado: (2004)

Update on first-line treatment of advanced ovarian carcinoma
por: Kemp, Z, et al.
Publicado: (2013)

Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis
por: Maggioni, A, et al.
Publicado: (2006)

Quality of life with cediranib in relapsed ovarian cancer: The ICON6 phase 3 randomized clinical trial
por: Stark, Dan P., et al.
Publicado: (2017)

Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone.
por: Lissoni, P., et al.
Publicado: (1995)

Speculation on optimal numbers of examined lymph node for early-stage epithelial ovarian cancer from the perspective of stage migration
por: Li, Yuan, et al.
Publicado: (2023)

Increasing experience in laparoscopic staging of early ovarian cancer
por: Schreuder, Henk W. R., et al.
Publicado: (2011)

First-line treatment for advanced ovarian cancer: paclitaxel, platinum and the evidence
por: Sandercock, J, et al.
Publicado: (2002)

Prognostic factors in early-stage ovarian cancer
por: Tognon, Germana, et al.
Publicado: (2013)

Ovarian cystectomy in the treatment of apparent early-stage immature teratoma
por: Zhao, Ting, et al.
Publicado: (2017)

Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract.
por: Lissoni, P., et al.
Publicado: (1993)

Highly-accurate metabolomic detection of early-stage ovarian cancer
por: Gaul, David A., et al.
Publicado: (2015)

Genomic aberrations relate early and advanced stage ovarian cancer
por: Zaal, Afra, et al.
Publicado: (2012)

Lipid Alterations in Early-Stage High-Grade Serous Ovarian Cancer
por: Iurova, M. V., et al.
Publicado: (2022)

Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer
por: González Martín, Antonio, et al.
Publicado: (2019)

How to optimize the treatment of early stage Parkinson’s disease
por: Stocchi, Fabrizio, et al.
Publicado: (2015)

Development of a Multiprotein Classifier for the Detection of Early Stage Ovarian Cancer
por: Boylan, Kristin L. M., et al.
Publicado: (2022)

Long-term results of fertility-sparing treatment compared with standard radical surgery for early-stage epithelial ovarian cancer
por: Fruscio, Robert, et al.
Publicado: (2016)

Optimal chemotherapy treatment for women with recurrent ovarian cancer
por: Fung-Kee-Fung, M., et al.
Publicado: (2007)

Early-Stage epithelial ovarian cancer: Predictors of survival
por: Upadhyay, Avinash, et al.
Publicado: (2022)

Immune checkpoint inhibitors in ovarian cancer: where do we stand?
por: Leary, Alexandra, et al.
Publicado: (2021)

Enhanced repair of DNA interstrand crosslinking in ovarian cancer cells from patients following treatment with platinum-based chemotherapy
por: Wynne, P, et al.
Publicado: (2007)

Surgical staging of apparent early-stage ovarian mucinous carcinoma
por: Yuan, Zhen, et al.
Publicado: (2022)

Early-stage epithelial ovarian cancer: is systematic lymph node staging mandatory?
por: Imterat, Majdi, et al.
Publicado: (2021)

Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial
por: Ledermann, J.A., et al.
Publicado: (2021)

Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based chemotherapy: an Italian Collaborative Study from the ‘Mario Negri’ Institute, Milan, G.O.N.O. (Gruppo Oncologico Nord Ovest) group and I.O.R. (Istituto Oncologico Romagnolo) group
por: Buda, A, et al.
Publicado: (2004)

No socioeconomic inequalities in ovarian cancer survival within two randomised clinical trials
por: Abdel-Rahman, M E, et al.
Publicado: (2014)

Early Stage Adenocarcinoma of Cervix with Ovarian Micrometastasis
por: Singh, Pratibha, et al.
Publicado: (2017)

Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer
por: Colombo, Nicoletta, et al.
Publicado: (2019)

Incomplete surgical staging in clinical early-stage ovarian cancer: guidelines versus daily practice
por: Laven, P, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ie4mom4627u08qbd11qejoat28